Anand Irimpen

Five-Year Outcomes with PCI Guided by Fractional Flow Reserve

Panagiotis Xaplanteris, Stéphane Fournier, Nico H.J. Pijls et al. · New England Journal of Medicine · 2018 · 861 citations · Full text

Medicine, Cardiology, Surgery +17

Efficacy and Safety of Automatic Remote Monitoring for Implantable Cardioverter-Defibrillator Follow-Up

Niraj Varma, Andrew E. Epstein, Anand Irimpen et al. · Circulation · 2010 · 586 citations

Medicine, Cardiology, Interventional Cardiology +16

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

Gregory G. Schwartz, Vera A. Bittner, Patricio López‐Jaramillo et al. · Journal of the American College of Cardiology · 2021 · 141 citations · Full text

Medicine, Cardiology, Pharmacology +17

OxLDL induces endothelial dysfunction and death via TRAF3IP2: Inhibition by HDL3 and AMPK activators

Anthony J. Valente, Anand Irimpen, Ulrich Siebenlist et al. · Free Radical Biology and Medicine · 2014 · 124 citations · Full text

Life Sciences, Cell Biology, Molecular Medicine +14